Answer
Bosutinib monohydrate can cause severe skin reactions such as Stevens–Johnson syndrome and toxic epidermal necrolysis, and treatment should be permanently discontinued if a severe skin reaction occurs.
Sources for this answer
- Bosulif 500mg Film Coated TabletsPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 31Document updated
Sources checked